Double-blind, placebo-controlled randomized trial with adalimumab for treatment of juvenile onset ankylosing spondylitis (JoAS): significant short term improvement

Overview of attention for article published in Arthritis Research & Therapy, October 2012

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 69 Dimensions

Readers on

mendeley: 96 Mendeley

Summary Policy documents Dimensions citations

So far, Dimensions has found 69 publications that cite this research output.

69

The most recent citing publications are shown below. View all 69 publications that cite this research output on Dimensions.

Comparative efficacy and safety of different drugs in patients with systemic juvenile idiopathic arthritis: A systematic review and network meta-analysis

Article in Medicine (May 2024)

A case of juvenile-onset ankylosing spondylitis effectively treated with tumour necrosis factor-alpha inhibitor agents

Article in Modern Rheumatology Case Reports (February 2024)

Comparison of biologics and small-molecule drugs in axial spondyloarthritis: a systematic review and network meta-analysis

Article in Frontiers in Pharmacology (October 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.